Immuno-modulation in Amyotrophic Lateral Sclerosis: a phase II study of safety and activity of low dose Interleukin-2

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/201930/06/2022

Funding

  • Nimes University Hospital Centre: £14,370.00